Computational Biology Division, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town, Cape Town, South Africa.
Ministry of Health (Guinea) and University of Conakry, Conakry, Guinea.
Trends Biotechnol. 2021 Feb;39(2):116-125. doi: 10.1016/j.tibtech.2020.06.009. Epub 2020 Jul 10.
The Nagoya Protocol (NP), a legal framework under the Convention on Biological Diversity (CBD), formalises fair and equitable sharing of benefits arising from biological diversity. It encompasses biological samples and associated indigenous knowledge, with equitable return of benefits to those providing samples. Recent proposals that the use of digital sequence information (DSI) derived from samples should also require benefit-sharing under the NP have raised concerns that this might hamper research progress. Here, we propose that formalised benefit-sharing for biological data use can increase willingness to participate in research and share data, by ensuring equitable collaboration between sample providers and researchers, and preventing exploitative practices. Three case studies demonstrate how equitable benefit-sharing agreements might build long-term collaborations, furthering research for global benefits.
《名古屋议定书》（NP）是《生物多样性公约》（CBD）下的一项法律框架，正式规定了公平公正地分享生物多样性所带来的惠益。它涵盖了生物样本和相关的土著知识，要求向提供样本的人公平地回报惠益。最近有人提议，从样本中衍生的数字序列信息（DSI）的使用也应该根据 NP 进行惠益分享，这引起了人们的担忧，认为这可能会阻碍研究进展。在这里，我们提出，通过确保样本提供者和研究人员之间的公平合作，并防止剥削性做法，对生物数据使用进行正式的惠益分享，可以增加参与研究和共享数据的意愿。三个案例研究表明，公平的惠益分享协议如何能够建立长期的合作关系，进一步为全球利益开展研究。
